Comparison of Quadroiliac Plane Block and Pericapsular Nerve Group (PENG) Block in Femoral Fractures
Launched by KANUNI SULTAN SULEYMAN TRAINING AND RESEARCH HOSPITAL · Sep 17, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods of pain relief after surgery for femoral neck fractures, which are breaks in the thigh bone near the hip. The two methods being compared are called the Quadroiliac Plane Block (QIPB) and the Pericapsular Nerve Group (PENG) block. Both methods are designed to help manage pain after surgery, and patients will be randomly assigned to receive one of these blocks while they are under spinal anesthesia. Experienced anesthesiologists will perform the procedures, and participants will be asked to share their pain levels at various times after surgery.
To be eligible for this study, participants need to be at least 18 years old and scheduled for femoral fracture surgery. They should not have any serious medical conditions that could complicate the procedure, such as bleeding issues or certain chronic diseases. Participants can expect to be involved in monitoring their pain and how much medication they need for pain relief after surgery. The trial is currently recruiting, and informed consent is required from both the patient and their family members before participating. This study aims to find out which pain relief method is more effective, ultimately helping improve care for patients with femur fractures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients and their relatives have provided informed consent,
- • Patients aged 18 years or older undergoing femoral fracture surgery,
- • ASA score of I-III,
- • No history of bleeding diathesis,
- • No history of anticoagulant use that contraindicates block application according to guidelines,
- • No history of neuropathic diseases such as Diabetes Mellitus,
- • No known allergy to local anesthetics.
- Exclusion Criteria:
- • Lack of informed consent from the patient or their relatives,
- • Development of complications during the surgical procedure,
- • Need for revision surgery,
- • Patient\'s desire to withdraw from the study,
- • Patients under the age of 18,
- • ASA score of IV or higher,
- • Patients with a history of bleeding diathesis,
- • History of anticoagulant use that contraindicates block application according to guidelines,
- • Emergency surgeries,
- • History of allergy to local anesthetics,
- • History of neuropathic diseases,
- • Inability to comply with patient-controlled analgesia (PCA) systems.
About Kanuni Sultan Suleyman Training And Research Hospital
Kanuni Sultan Suleyman Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical knowledge and improving patient care through rigorous clinical research. As a leading sponsor of clinical trials, the hospital fosters innovation by collaborating with multidisciplinary teams of healthcare professionals and researchers to investigate new treatment modalities and therapeutic options. Committed to ethical standards and patient safety, the hospital plays a vital role in translating research findings into clinical practice, thereby contributing to the enhancement of health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported